Insights & Blog

No items available

In the Spotlight

Attempting to harness the body’s adaptive defense system into a drug? In this post, discover different factors to consider when trying to strike the right balance between the safety and efficacy of your antibody.

An interview with Scientific Advisor Erika Fletcher. To the clients she works with, Erika Fletcher’s sharp scientific mind is one of Immuneed’s strongest assets.

New paper featuring Immuneed. Donor-specific immune effector signatures of CLL patients in response to anti-CD20.

The spark behind Immuneed. An interview with founder Sara Mangsbo.